Avastin (bevacizumab) is a drug owned by Genentech for the treatment of colon cancer.
Other SourceWatch Resources
- Us Food and Drug Administration Center for Drug Evaluation and Research, "Avastin (bevacizumab)], Created February 26, 2004; Updated June 28, 2006.
- Jeanne Lenzer , "Ties between regulators and business are attacked after politician takes top job in industry", British Medical Journal, January 8, 2005.
|This article is a stub. You can help by expanding it.|